Antivert and Ejection fraction abnormal - a phase IV clinical study of FDA data

Summary:

Ejection fraction abnormal is reported as a side effect among people who take Antivert (meclizine hydrochloride), especially for people who are 40-49 old, also take Coumadin,.

The phase IV clinical study analyzes which people have Ejection fraction abnormal when taking Antivert. It is created by eHealthMe based on reports of 3,935 people who have side effects when taking Antivert from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Ejection fraction abnormal?

Ejection fraction abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat) is found to be associated with 441 drugs and 356 conditions by eHealthMe. Check the latest studies of Ejection fraction abnormal.



On Jul, 12, 2026

3,935 people reported to have side effects when taking Antivert.
Among them, 14 people (0.36%) have Ejection fraction abnormal.

Could Antivert cause Ejection fraction abnormal?

Among these 14 people:

What is the age of people who have Ejection fraction abnormal when taking Antivert? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 10 %
  • 40-49: 70 %
  • 50-59: 0.0 %
  • 60+: 20 %

What are other drugs people take besides Antivert? *

  1. Zometa: 11 people, 78.57%
  2. Cymbalta: 11 people, 78.57%
  3. Pantoprazole: 11 people, 78.57%
  4. Ondansetron: 11 people, 78.57%
  5. Novolog: 11 people, 78.57%
  6. Naloxone: 11 people, 78.57%
  7. Mycophenolic Acid: 11 people, 78.57%
  8. Lantus: 11 people, 78.57%
  9. Entocort Ec: 11 people, 78.57%
  10. Coumadin: 11 people, 78.57%

What are other side effects people have besides Ejection fraction abnormal? *

  1. Gastritis (inflammation of stomach): 11 people, 78.57%
  2. High Blood Pressure: 11 people, 78.57%
  3. Candidiasis (candidiasis or thrush is a fungal infection): 11 people, 78.57%
  4. Neuropathy Peripheral (surface nerve damage): 11 people, 78.57%
  5. Neoplasm Malignant (cancer tumour): 11 people, 78.57%
  6. Cardiomyopathy (weakening of the heart muscle): 11 people, 78.57%
  7. Gastric Polyps (abnormal growth of stomach tissue projecting from a mucous membrane): 11 people, 78.57%
  8. Metastases To Bone Marrow (cancer spreads to bone marrow): 11 people, 78.57%
  9. Cyst (a closed sac): 11 people, 78.57%
  10. Cytomegalovirus Infection: 11 people, 78.57%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and have Ejection fraction abnormal?

- Check whether Ejection fraction abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Antivert:

Ejection fraction abnormal treatments and more:

How severe was Ejection fraction abnormal and when was it recovered:

Expand to all the drugs that have ingredients of meclizine hydrochloride:

Sub-studies by age:

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ejection fraction abnormal:

Browse all the conditions that are associated with Ejection fraction abnormal:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride (the active ingredients of Antivert) and Antivert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: